We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Screening and Genetic Monitoring of Patients With Myelodysplastic Syndromes (MDS) Under Different Treatment Modalities by Cytogenetic Analyses of Circulating CD34+Cells

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01355913
Recruitment Status : Active, not recruiting
First Posted : May 18, 2011
Last Update Posted : October 25, 2017
University Medical Center Goettingen
Information provided by:
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : October 2016
  Estimated Study Completion Date : October 2019
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):